Healthcare & Life Sciences

Pano Therapeutics

Pano Therapeutics is a Healthcare & Life Sciences startup based in the United States.

About Pano Therapeutics

Based in the United States, Pano Therapeutics is a startup. Brouky classifies it under Healthcare & Life Sciences.

Pano Therapeutics is developing PAN1195, an oral, once-daily CNS-optimized biguanide aimed at treating Fragile X Syndrome and related syndromic neurodevelopmental disorders through targeted pharmacology.

Explore Pano Therapeutics's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

View Startup Profile →View pricing

Other Startups in United States

All startups →

Panoramic Powerseries-b Panorama Educationseries-c-plus Panoptoseries-b Panoptive Panomicsseries-b Panome Bioseed Pantero Panthalassaseries-b Pantheon Systemsseries-c-plus Pantherseed Panthera Biopartnersseries-b Panther Globalseed